The Molecular Imaging and Therapeutics (formerly Nuclear Medicine) section of the Department of Radiology at WCM seeks a full-time faculty member at the level of Assistant or Associate Professor with clinical experience in general nuclear medicine and PET/CT to support clinical care, education and research in hybrid imaging modalities including PET/CT, SPECT/CT and PET/MR. An ideal candidate will have clinical skills in PET/CT and strong interest in developing PET/MR applications. Given the rise of fusion modalities, an interest in combining clinical responsibilities with another clinical service in Radiology can be discussed on a case-by-case basis. Board certification with the ABNM and authorized user status will be an asset given the growing therapeutic applications.
Division of Molecular Imaging & Therapeutics
The Division of Molecular Imaging and Therapeutics uses imaging probes to diagnose and treat disease. We perform standard Nuclear Medicine procedures as well as multiple clinical trials with antibodies and small molecules tagged with Lutetium-177, Yttrium-90 and Actinium 225. We provide multiple Prostate Cancer therapies with radiolabeled PSMA in conjunction with genitourinary oncology, multiple PET and PET/MR probes investigating Dementia and Neurooncology and are beginning several investigations in Endocrine oncology.
Clinical equipment includes:
2 Siemens mMR PET/MRI Scanners
1 GE PET/MR Scanner
1 GE Millenium MPS Single-head camcer
2 GE Optimate 3/8" Crystal, Dual Head Cameras
2 GE Discovery 3/8 Crystal, Dual Head SPECT cameras
4 Siemens mCT PET/CT Scanners
Department of Radiology
The Department of Radiology at WCM is a thriving academic department focused on both clinical service and academic development and research, receiving over $20 million in active grant funding from federal agencies (NIH), foundations, and industry. The Department of Radiology consistently ranks in the top 20 radiology departments in regards to NIH funding. There are over 100 faculty in the department with subspecialty focuses spanning the entire spectrum of imaging applications. The department has a rapidly growing clinical service in both the inpatient and outpatient practice settings, providing high-quality and safe imaging to patient. Recent acquisitions of cutting-edge imaging technology in the department have included the purchase of state-of-the-art equipment for advanced imaging in computed tomography (CT), magnetic resonance imaging (MRI), positron emission tomography (PET), and molecular MRI.
Qualified applicants must be ABNM or ABR eligible. Applicants must be able to obtain a New York State medical license.
Interested applicants should send a curriculum vitae and letter of intent to:
Assistant to Division Director
Department of Radiology – Molecular Imaging and Therapeutics Division
NewYork-Presbyterian Hospital/Weill Cornell Medicine